Laura Ridolfi

2.2k total citations
67 papers, 1.6k citations indexed

About

Laura Ridolfi is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Laura Ridolfi has authored 67 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Oncology, 42 papers in Immunology and 21 papers in Molecular Biology. Recurrent topics in Laura Ridolfi's work include Immunotherapy and Immune Responses (38 papers), Cancer Immunotherapy and Biomarkers (33 papers) and CAR-T cell therapy research (19 papers). Laura Ridolfi is often cited by papers focused on Immunotherapy and Immune Responses (38 papers), Cancer Immunotherapy and Biomarkers (33 papers) and CAR-T cell therapy research (19 papers). Laura Ridolfi collaborates with scholars based in Italy, United States and India. Laura Ridolfi's co-authors include Ruggero Ridolfi, Michele Guida, Angela Riccobon, Steinar Aamdal, Johan Hansson, David M. Berman, Lars Bastholt, Omid Hamid, David M. Hyams and Aviram Nissan and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Cancer and Annals of Oncology.

In The Last Decade

Laura Ridolfi

64 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Laura Ridolfi Italy 20 1.2k 877 463 309 110 67 1.6k
Riccardo Danielli Italy 22 1.4k 1.2× 1.0k 1.2× 728 1.6× 621 2.0× 133 1.2× 45 2.4k
Marta Nyakas Norway 21 1.1k 1.0× 738 0.8× 670 1.4× 157 0.5× 99 0.9× 49 1.6k
Hojabr Kakavand Australia 15 1.1k 1.0× 583 0.7× 501 1.1× 179 0.6× 162 1.5× 20 1.4k
Jean-Jacques Grob France 7 1.4k 1.2× 541 0.6× 547 1.2× 243 0.8× 84 0.8× 9 1.6k
Aniruddha Choudhury Sweden 20 909 0.8× 1.2k 1.3× 460 1.0× 111 0.4× 74 0.7× 38 1.7k
Antonia Busse Germany 19 567 0.5× 461 0.5× 495 1.1× 88 0.3× 106 1.0× 54 1.1k
Micaela Hernberg Finland 20 680 0.6× 419 0.5× 408 0.9× 148 0.5× 107 1.0× 58 1.1k
Jennifer Landsberg Germany 23 676 0.6× 454 0.5× 595 1.3× 264 0.9× 231 2.1× 58 1.4k
Ana Carneiro Sweden 16 650 0.6× 272 0.3× 467 1.0× 203 0.7× 145 1.3× 46 1.1k
Jarem Edwards Australia 15 962 0.8× 673 0.8× 338 0.7× 448 1.4× 56 0.5× 18 1.5k

Countries citing papers authored by Laura Ridolfi

Since Specialization
Citations

This map shows the geographic impact of Laura Ridolfi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura Ridolfi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura Ridolfi more than expected).

Fields of papers citing papers by Laura Ridolfi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura Ridolfi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura Ridolfi. The network helps show where Laura Ridolfi may publish in the future.

Co-authorship network of co-authors of Laura Ridolfi

This figure shows the co-authorship network connecting the top 25 collaborators of Laura Ridolfi. A scholar is included among the top collaborators of Laura Ridolfi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura Ridolfi. Laura Ridolfi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Arienti, Chiara, Francesca Fanini, Sara Pignatta, et al.. (2024). In vitro CAR-T cell killing: validation of the potency assay. Cancer Immunology Immunotherapy. 73(9). 168–168.
2.
Schepisi, Giuseppe, Caterina Gianni, Michela Palleschi, et al.. (2023). The New Frontier of Immunotherapy: Chimeric Antigen Receptor T (CAR-T) Cell and Macrophage (CAR-M) Therapy against Breast Cancer. Cancers. 15(5). 1597–1597. 31 indexed citations
3.
Matteucci, Laura, Alessandro Bittoni, Graziana Gallo, Laura Ridolfi, & Alessandro Passardi. (2023). Immunocheckpoint Inhibitors in Microsatellite-Stable or Proficient Mismatch Repair Metastatic Colorectal Cancer: Are We Entering a New Era?. Cancers. 15(21). 5189–5189. 3 indexed citations
4.
Granato, Anna Maria, Emanuela Scarpi, Laura Ridolfi, et al.. (2022). Stability Program in Dendritic Cell Vaccines: A “Real-World” Experience in the Immuno-Gene Therapy Factory of Romagna Cancer Center. Vaccines. 10(7). 999–999. 5 indexed citations
5.
Guida, Michele, Nicola Bartolomeo, Davide Quaresmini, et al.. (2022). Basal and one-month differed neutrophil, lymphocyte and platelet values and their ratios strongly predict the efficacy of checkpoint inhibitors immunotherapy in patients with advanced BRAF wild-type melanoma. Journal of Translational Medicine. 20(1). 159–159. 19 indexed citations
6.
Guida, Michele, Nicola Bartolomeo, Pietro Quaglino, et al.. (2021). No Impact of NRAS Mutation on Features of Primary and Metastatic Melanoma or on Outcomes of Checkpoint Inhibitor Immunotherapy: An Italian Melanoma Intergroup (IMI) Study. Cancers. 13(3). 475–475. 19 indexed citations
7.
Bulgarelli, Jenny, Marcella Tazzari, Anna Maria Granato, et al.. (2019). Dendritic Cell Vaccination in Metastatic Melanoma Turns “Non-T Cell Inflamed” Into “T-Cell Inflamed” Tumors. Frontiers in Immunology. 10. 2353–2353. 24 indexed citations
8.
9.
Procopio, Giuseppe, Elena Verzoni, Sergio Bracarda, et al.. (2013). Overall survival for sorafenib plus interleukin-2 compared with sorafenib alone in metastatic renal cell carcinoma (mRCC): final results of the ROSORC trial. Annals of Oncology. 24(12). 2967–2971. 24 indexed citations
10.
Milandri, Carlo, R. Polico, Domenico Garcea, et al.. (2011). GEMOX plus tomotherapy for unresectable locally advanced pancreatic cancer.. PubMed. 58(106). 20–21. 7 indexed citations
11.
Farolfi, Alberto, Laura Ridolfi, Massimo Guidoboni, et al.. (2011). Liver Metastases from Melanoma: Hepatic Intra-Arterial Chemotherapy. A Retrospective Study. Journal of Chemotherapy. 23(5). 300–305. 14 indexed citations
12.
Ridolfi, Laura, Massimiliano Petrini, Laura Fiammenghi, et al.. (2011). Dendritic cell-based vaccine in advanced melanoma. Melanoma Research. 21(6). 524–529. 27 indexed citations
13.
Ridolfi, Laura. (2011). Chemotherapy with or without low-dose interleukin-2 in advanced non-small cell lung cancer: results from a phase III randomized multicentric trial. International Journal of Oncology. 39(4). 1011–7. 31 indexed citations
14.
Procopio, Giuseppe, Elena Verzoni, Sergio Bracarda, et al.. (2011). Sorafenib with interleukin-2 vs sorafenib alone in metastatic renal cell carcinoma: the ROSORC trial. British Journal of Cancer. 104(8). 1256–1261. 54 indexed citations
15.
Chiarion‐Sileni, Vanna, Michele Guida, Laura Ridolfi, et al.. (2011). Central nervous system failure in melanoma patients: results of a randomised, multicentre phase 3 study of temozolomide- and dacarbazine- based regimens. British Journal of Cancer. 104(12). 1816–1821. 45 indexed citations
16.
Ridolfi, Laura, Massimiliano Petrini, Laura Fiammenghi, et al.. (2010). Unexpected High Response Rate to Traditional Therapy after Dendritic Cell‐Based Vaccine in Advanced Melanoma: Update of Clinical Outcome and Subgroup Analysis. Journal of Immunology Research. 2010(1). 15 indexed citations
17.
Cavaliere, Davide, Gianni Mura, Massimo Framarini, et al.. (2007). Downstaging of a gastric GIST by neoadjuvant imatinib and endoscopic assisted laparoscopic resection. European Journal of Surgical Oncology. 33(8). 1044–1046. 7 indexed citations
18.
Ridolfi, Ruggero, Angela Riccobon, Riccardo Galassi, et al.. (2004). Evaluation of in vivo labelled dendritic cell migration in cancer patients. Journal of Translational Medicine. 2(1). 27–27. 100 indexed citations
19.
Ridolfi, Laura, Ruggero Ridolfi, Angela Riccobon, et al.. (2003). Adjuvant Immunotherapy With Tumor Infiltrating Lymphocytes and Interleukin-2 in Patients With Resected Stage III and IV Melanoma. Journal of Immunotherapy. 26(2). 156–162. 17 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Riccardo Danielli Breakdown of academic impact, for papers by Marta Nyakas Breakdown of academic impact, for papers by Hojabr Kakavand Breakdown of academic impact, for papers by Jean-Jacques Grob Breakdown of academic impact, for papers by Aniruddha Choudhury Breakdown of academic impact, for papers by Antonia Busse Breakdown of academic impact, for papers by Micaela Hernberg Breakdown of academic impact, for papers by Jennifer Landsberg Breakdown of academic impact, for papers by Ana Carneiro Breakdown of academic impact, for papers by Jarem Edwards
Rankless by CCL
2026